Edoardo Scarpa
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- Hydrogels: synthesis, properties, applications
Papers in
-
- RNA Interference and Gene Delivery 6
- Wnt/β-catenin signaling in development and cancer 3
- Biomaterials 10
- Nanoparticle-Based Drug Delivery 9
- Co-authors
- Richard O. C. Oreffo (5 shared papers)Giuseppe Battaglia (10 shared papers)Loris Rizzello (16 shared papers)Alessandro Poma (7 shared papers)Nicholas D. Evans (4 shared papers)David Gibbs (1 shared paper)Tracey A. Newman (4 shared papers)Cameron Black (1 shared paper)
- Journals
- Molecular Pharmaceutics (2 papers)Biomaterials (2 papers)Advanced Therapeutics (2 papers)Stem Cells (1 paper)Scientific Reports (1 paper)
- Partner nations
- ItalyUnited KingdomSpain
In The Last Decade
Edoardo Scarpa
32 papers receiving 475 citations
Peers
Comparison fields: 5 of 99
- Biomaterials 138
- Molecular Medicine 32
- Pharmaceutical Science 27
- Biomedical Engineering 190
- Complementary and Manual Therapy 9
Countries citing papers authored by Edoardo Scarpa
This map shows the geographic impact of Edoardo Scarpa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edoardo Scarpa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edoardo Scarpa more than expected).
Fields of papers citing papers by Edoardo Scarpa
This network shows the impact of papers produced by Edoardo Scarpa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edoardo Scarpa. The network helps show where Edoardo Scarpa may publish in the future.
Co-authors
The 25 scholars most cited alongside Edoardo Scarpa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 73 | |
| 2 | 2020 | 58 | |
| 3 | 2020 | 51 | |
| 4 | 2016 | 48 | |
| 5 | 2018 | 35 | |
| 6 | 2020 | 25 | |
| 7 | 2023 | 20 | |
| 8 | 2022 | 17 | |
| 9 | 2018 | 17 | |
| 10 | 2021 | 15 | |
| 11 | 2017 | 15 | |
| 12 | 2014 | 13 | |
| 13 | 2015 | 13 | |
| 14 | 2022 | 11 | |
| 15 | 2015 | 11 | |
| 16 | 2020 | 10 | |
| 17 | 2020 | 9 | |
| 18 | 2021 | 7 | |
| 19 | 2015 | 5 | |
| 20 | 2021 | 5 |
About Edoardo Scarpa
Edoardo Scarpa is a scholar working on Molecular Biology, Biomaterials, Surgery, Biomedical Engineering and Cell Biology, having authored 33 papers that have together received 481 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (9 papers), RNA Interference and Gene Delivery (6 papers), Wnt/β-catenin signaling in development and cancer (3 papers), Nanoparticles: synthesis and applications (3 papers), Advanced Drug Delivery Systems (3 papers), Nanoplatforms for cancer theranostics (2 papers), Tendon Structure and Treatment (2 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). The work is most often cited by research in Biomaterials (138 citations), Molecular Medicine (32 citations), Pharmaceutical Science (27 citations), Biomedical Engineering (190 citations) and Complementary and Manual Therapy (9 citations). Edoardo Scarpa has collaborated with scholars based in Italy, United Kingdom and Spain. Frequent co-authors include Richard O. C. Oreffo, Giuseppe Battaglia, Loris Rizzello, Alessandro Poma, Nicholas D. Evans, David Gibbs, Tracey A. Newman, Cameron Black, Pujiang Shi and Jonathan I. Dawson. Their work appears in journals such as Molecular Pharmaceutics, Biomaterials, Advanced Therapeutics, Stem Cells and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.